Telix Pharmaceuticals Limited
TLX.ASXHealth Care
Development and commercialising molecularly targeted radiation products for the treatment of cancer.
Market Data
$14.910
+0.0%$5.0B
-100000.0x
$-0.030
0.00%
-0.1%
Recent Announcements
Ceasing to be a substantial holder
Citigroup Global Markets Australia Pty Limited (ACN 003 114 832) ceased to be a substantial holder.
Becoming a substantial holder
Citigroup Global Markets Australia Pty Limited (ACN 003 114 832) became a substantial holder (6.5532%).
Becoming a substantial holder
Vanguard Group (The Vanguard Group, Inc. became a substantial holder (5.217%).
Ceasing to be a substantial holder
Citigroup Global Markets Australia Pty Limited (ACN 003 114 832) ceased to be a substantial holder.
Becoming a substantial holder
Citigroup Global Markets Australia Pty Limited (ACN 003 114 832) became a substantial holder (5.9153%).
Becoming a substantial holder from CGF
CGF became a substantial holder (5.24%).
Ceasing to be a substantial holder
Citigroup Global Markets Australia Pty Limited (ACN 003 114 832) ceased to be a substantial holder.
Becoming a substantial holder
Citigroup Global Markets Australia Pty Limited (ACN 003 114 832) became a substantial holder (5.3084%).
Ceasing to be a substantial holder from CGF
CGF ceased to be a substantial holder.
Ceasing to be a substantial holder
Citigroup Global Markets Australia Pty Limited (ACN 003 114 832) ceased to be a substantial holder.
Get real-time alerts for TLX
Receive AI-powered earnings summaries and instant notifications when Telix Pharmaceuticals Limited releases results.
Register Free